Alembic Pharmaceuticals Limited (APLLTD) — Capital Reinvestment Ratio

Latest as of September 2025: 0.71x

Alembic Pharmaceuticals Limited (APLLTD) has a Capital Reinvestment Ratio of 0.71x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs4.03 Billion) in capital expenditures (Rs2.88 Billion). See Alembic Pharmaceuticals Limited free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.71x
Capex / Operating Cash Flow

Operating Cash Flow

Rs4.03 Billion
INR

Capital Expenditures

Rs2.88 Billion
INR

Data as of

Sep 2025
Most recent filing

Alembic Pharmaceuticals Limited Capital Reinvestment Ratio (2011–2025)

This chart tracks Alembic Pharmaceuticals Limited's Capital Reinvestment Ratio across 15 annual periods.

Annual Capital Reinvestment Ratio for Alembic Pharmaceuticals Limited (2011–2025)

Year-by-year Capital Reinvestment Ratio for Alembic Pharmaceuticals Limited from 2011 to 2025. For live market cap and broader valuation context, see APLLTD market cap overview.

Year Reinvestment Ratio Operating CF (INR) Capital Expenditures YoY Change
2025 6.41x Rs879.70 Million Rs5.64 Billion ▲ +1471.5%
2024 0.41x Rs8.03 Billion Rs3.27 Billion ▼ -33.4%
2023 0.61x Rs7.24 Billion Rs4.43 Billion ▼ -20.5%
2022 0.77x Rs5.52 Billion Rs4.26 Billion ▲ +71.0%
2021 0.45x Rs14.63 Billion Rs6.60 Billion ▼ -72.5%
2020 1.64x Rs4.49 Billion Rs7.35 Billion ▲ +73.8%
2019 0.94x Rs8.12 Billion Rs7.64 Billion ▼ -64.2%
2018 2.63x Rs3.12 Billion Rs8.22 Billion ▲ +61.5%
2017 1.63x Rs2.89 Billion Rs4.70 Billion ▲ +399.1%
2016 0.33x Rs9.30 Billion Rs3.04 Billion ▼ -74.9%
2015 1.30x Rs1.72 Billion Rs2.24 Billion ▲ +275.2%
2014 0.35x Rs2.36 Billion Rs819.63 Million ▲ +6.9%
2013 0.32x Rs2.65 Billion Rs859.73 Million ▼ -25.4%
2012 0.44x Rs1.41 Billion Rs612.56 Million ▼ -33.1%
2011 0.65x Rs961.81 Million Rs625.38 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow